Dose of relief

Are generic drugs just what the cost-cutters ordered? As healthcare prices spiral upward, some are encouraged by an emerging trend: Key drugs are losing patent protection. Now they look to the FDA to unclog the approval pipeline for generics.

By Diedtra Henderson

Globe Staff / April 30, 2006

E-mail|
Reprints|

Text size – +

WASHINGTON -- They're not sexy. They're not the darlings of multimillion-dollar advertising campaigns. But, generic drugs account for more than half of prescriptions written and, with the advent of the Medicare prescription drug benefit, members of Congress want to tap generics' savings potential. (Full article: 1021 words)